Medigenebio Corporation
Records under this name other than the patents Medigenebio Corporation holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.
Showing 1 to 6 of 6 · Back to Medigenebio Corporation
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,249,397 | Composition and formulation comprising recombinant human iduronate-2-sulfatase and preparation method thereof Formerly held In force · USPTO record | In force | USPTO record | |
| US 9,896,672 | Composition and formulation comprising recombinant human iduronate-2-sulfatase and preparation method thereof Formerly held In force · USPTO record | In force | USPTO record | |
| US 10,174,299 | Composition and formulation comprising recombinant human iduronate-2-sulfatase and preparation method thereof Formerly held In force · USPTO record | In force | USPTO record | |
| US 9,206,402 | Composition and formulation comprising recombinant human iduronate-2-sulfatase and preparation method thereof Formerly held In force · USPTO record | In force | USPTO record | |
| US 10,561,713 | Hunter syndrome therapeutic agent and treatment method Formerly held In force · USPTO record | In force | USPTO record | |
| US 11,052,135 | Methods and Compositions for Treating Hunter Syndrome Formerly held In force · High confidence | In force | High confidence |